Lista de obras - Yusuf Yilmaz - Dominio Público Uruguay

"Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18

artículo científico publicado en 2009

A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments

artículo científico publicado en 2008

A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease

artículo científico publicado en 2014

Acute arsenic self-poisoning for suicidal purpose in a dentist: a case report

artículo científico publicado en 2009

Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia

artículo científico publicado en 2008

Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.

artículo científico publicado en 2010

Apoptosis: why and how does it occur in biology?

artículo científico publicado en 2011

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2012

Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans

artículo científico publicado en 2011

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

artículo científico publicado en 2014

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.

artículo científico publicado en 2009

Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials.

artículo científico

Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?

artículo científico publicado en 2009

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B

artículo científico publicado en 2010

Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease

artículo científico publicado en 2010

Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease

artículo científico publicado en 2011

Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis ⬇️

artículo científico publicado el 19 de diciembre de 2011

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2011

Clinical Value of the Malnutrition-Inflammation-Atherosclerosis Syndrome for Long-Term Prediction of Cardiovascular Mortality in Patients with End-Stage Renal Disease: A 5-Year Prospective Study

artículo científico publicado en 2008

Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease

artículo científico publicado en 2020

Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease"

artículo científico publicado en 2009

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients

artículo científico publicado en 2009

Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

artículo científico publicado en 2012

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis

artículo científico publicado en 2010

Cytokeratins in hepatitis.

artículo científico

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2009

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

artículo científico publicado en 2014

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

artículo científico publicado en 2021

Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease

artículo científico publicado en 2008

Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease

artículo científico publicado en 2008

Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients.

artículo científico publicado en 2007

Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency

artículo científico publicado en 2010

Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease

artículo científico publicado en 2014

Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2012

Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease

scientific article published on 24 July 2019

Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count

artículo científico publicado en 2009

Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis

artículo científico publicado en 2012

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2010

Is M65 really better than M30 as a biomarker of hepatic fibrosis?

artículo científico publicado en 2012

Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?

artículo científico publicado en 2012

Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori

scientific article published on 27 December 2010

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population

artículo científico publicado en 2020

Letter: diagnostic accuracy of M30 levels for identifying patients with non‐alcoholic steatohepatitis ⬇️

artículo científico publicado el 1 de enero de 2013

Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply

artículo científico publicado en 2014

Letter: the perilous road to a functional cure for hepatitis B infection

artículo científico publicado en 2020

Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening

artículo científico publicado en 2020

Liver disease and malnutrition.

artículo científico

Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue

artículo científico publicado en 2009

Liver enzymes and cardiovascular outcomes: A new research agenda ⬇️

artículo científico publicado el 30 de junio de 2010

Liver function tests: Association with cardiovascular outcomes ⬇️

artículo científico publicado el 27 de abril de 2010

Metformin, hepatitis C, and insulin resistance: sufficient evidence?

artículo científico publicado en 2009

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

artículo científico publicado en 2010

Molecular signatures of nonalcoholic fatty liver disease: the present and future

artículo científico publicado en 2010

Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats

artículo científico publicado en 2011

NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?

artículo científico publicado en 2012

NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?

artículo científico publicado en 2019

Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance

artículo científico publicado en 2009

Nonalcoholic Fatty Liver Disease: A Nutritional Approach ⬇️

artículo científico publicado el 6 de marzo de 2012

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography

artículo científico publicado en 2013

Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Obesity-associated nonalcoholic fatty liver disease.

artículo científico

Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease

artículo científico publicado el 1 de noviembre de 2011

Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis

artículo científico publicado en 2010

Predictive value of the modified Early Warning Score in a Turkish emergency department

scientific article published on 01 December 2008

Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

article

Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population

scientific article published on 26 September 2011

Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy

artículo científico publicado en 2011

Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry

artículo científico publicado en 2009

Psychopathology in the context of obesity: the adiponectin hypothesis

artículo científico publicado en 2007

Research update for articles published in EJCI in 2010

Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.

artículo científico

Review article: fructose in non‐alcoholic fatty liver disease ⬇️

artículo científico publicado el 2 de abril de 2012

Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions? ⬇️

artículo científico publicado el 1 de noviembre de 2012

Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.

artículo científico

Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease

artículo científico publicado en 2009

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

artículo científico publicado en 2009

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.

artículo científico publicado en 2009

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology

scientific article published on 01 March 2012

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

scientific article published on 06 October 2010

Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2011

Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis

artículo científico publicado en 2009

Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.

artículo científico publicado en 2011

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

artículo científico publicado en 2010

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

scientific article published on 14 October 2010

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity ⬇️

artículo científico publicado el 15 de abril de 2011

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2010

Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration

scientific article published on 22 August 2011

Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2012

Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis

scientific article published on 24 August 2011

Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 1 de enero de 2011

Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 23 de abril de 2012

Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2010

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid

scientific article published on 22 April 2008

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

artículo científico publicado en 2009

The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease

artículo científico publicado en 2008

The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.

artículo científico publicado en 2008

The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy

artículo científico publicado en 2011

The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond

artículo científico publicado en 2009

Unconjugated hyperbilirubinemia and liver histology in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2012

Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention?

artículo científico publicado en 2008

Lista de obras de Yusuf Yilmaz

"Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18

A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments

A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease

Acute arsenic self-poisoning for suicidal purpose in a dentist: a case report

Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia

Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.

Apoptosis: why and how does it occur in biology?

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.

Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials.

Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B

Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease

Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease

Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis ⬇️

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

Clinical Value of the Malnutrition-Inflammation-Atherosclerosis Syndrome for Long-Term Prediction of Cardiovascular Mortality in Patients with End-Stage Renal Disease: A 5-Year Prospective Study

Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease

Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease"

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients

Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis

Cytokeratins in hepatitis.

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease

Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease

Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients.

Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency

Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease

Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease

Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count

Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

Is M65 really better than M30 as a biomarker of hepatic fibrosis?

Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?

Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population

Letter: diagnostic accuracy of M30 levels for identifying patients with non‐alcoholic steatohepatitis ⬇️

Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply

Letter: the perilous road to a functional cure for hepatitis B infection

Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening

Liver disease and malnutrition.

Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue

Liver enzymes and cardiovascular outcomes: A new research agenda ⬇️

Liver function tests: Association with cardiovascular outcomes ⬇️

Metformin, hepatitis C, and insulin resistance: sufficient evidence?

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

Molecular signatures of nonalcoholic fatty liver disease: the present and future

Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats

NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?

NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?

Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance

Nonalcoholic Fatty Liver Disease: A Nutritional Approach ⬇️

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography

Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease

Obesity-associated nonalcoholic fatty liver disease.

Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease

Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis

Predictive value of the modified Early Warning Score in a Turkish emergency department

Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population

Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy

Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry

Psychopathology in the context of obesity: the adiponectin hypothesis

Research update for articles published in EJCI in 2010

Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.

Review article: fructose in non‐alcoholic fatty liver disease ⬇️

Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions? ⬇️

Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.

Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology